Whereas these data may suggest FGFR3 as a potential target for therapeutic prevention, further complementary analyses suggested lower FGFR3 may increase the risk of osteoarthritis, a common source of morbidity among older populations, and rare variant studies show that damaged FGFR3 increases the risk of bone disorders. The gene discussed is FGFR3; the disease is osteoarthritis.